Long-term treatment with allergoid immunotherapy with Parietaria. Clinical and immunologic effects in a randomized, controlled trial

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 54, Issue 4, 1999, Pages 313-319

  Ariano, R ^c   Kroon, A M ^a   Augeri, G ^c   Canonica, G W ^b   Passalacqua, G ^b,c  

^a Haarlem Allergen Labs BV   (Netherlands)

^b UNIVERSITY OF GENOA   (Italy)

^c Padiglione Maragliano ^*

Author keywords

Allergoid; Parietaria pollen; Specific immunotherapy

Indexed keywords

ALLERGEN;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; IMMUNOTHERAPY; MALE; POLLEN; POLLEN ALLERGY; PRIORITY JOURNAL; RATING SCALE; RESPIRATORY TRACT ALLERGY; RHINOCONJUNCTIVITIS; SYMPTOMATOLOGY;

ADOLESCENT; ADULT; ASTHMA; CONJUNCTIVITIS, ALLERGIC; DESENSITIZATION, IMMUNOLOGIC; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; MIDDLE AGED; PLANT EXTRACTS; POLLEN; RHINITIS, ALLERGIC, PERENNIAL; TREATMENT OUTCOME;

EID: 0001177594     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1398-9995.1999.00900.x     Document Type: Article

References (18)

1. 1. Allergen immunotherapy: therapeutical vaccines for allergic diseases. Bousquet J, Lockey RF, Malling H-J, editors. In: WHO position paper. Allergy 1998;53 Suppl 44:1-12.
2. 2. EAACI position paper on allergen immunotherapy. Malling H-J, Weeke B, editors. Allergy 1993;48 Suppl 14:9-35.
3. 3. British Society of Allergy and Clinical Immunology. Position paper on allergen immunotherapy. Clin Exp Allergy 1993;23:3-14.
4. 4. Abramson MJ, Puy RM, Weiner JM. Is allergen specific immunotherapy effective in asthma? Am J Respir Crit Care Med 1995;151:969-974.
5. 5. Norman PS. WHO-IUIS International Standards. Advantages of these extracts. Arb Paul Ehrlich Inst Bundesamt Sera Impfstoffe Frankf A M 1994;87:59-64.
6. 6. Passalacqua G, Canonica GW. Alternative routes for immunotherapy. J Invest Allergol Clin Immunol 1996;6:81-86.
7. 7. Grammer LC, Shaughnessy MA, Patterson R. Modified forms of allergen immunotherapy. J Allergy Clin Immunol 1985;76:397-401.
8. 8. Marsh DG, Norman PS, Roebber M, Lichtenstein LM. Studies of allergoids from naturally occurring allergens. III. Preparation of ragweed pollen allergoids by aldehyde modification in two steps. J Allergy Clin Immunol 1981;68:449-459.
9. 9. Bousquet J, Heijaoui A, Soussana M, Michel FB. Double blind placebo controlled immunotherapy with mixed grass pollen allergoids. IV. Comparison of the efficacy and safety of two dosages of a high molecular weight allergoid. J Allergy Clin Immunol 1990;85:490-497.
10. 10. Pastorello EA, Pravettoni V, Incorvaia C, Ortolani C. Clinical and immunological effects of immunotherapy with alum absorbed grass allergoid in grass pollen induced hay fever. Allergy 1992;47:281-290.
11. 11. Merincy DK, Kothari H, Chinoy P, Grieco MH. The clinical and immunological efficacy of immunotherapy with modified ragweed extract (allergoid) for ragweed hay fever. Ann Allergy 1986;56:34-38.
12. 12. Grammer LC, Shaughnessy SA, Suszko IM, Shaughnessy JJ, Patterson R. Persistence of efficacy after a brief course of polymerized ragweed allergen: a controlled study. J Allergy Clin Immunol 1984;73:484-489.
13. 13. Hedlin G, Heilborn H, Liljia G, Løwenstein H. Long-term follow up of patients treated with a three-year course of cat or dog immunotherapy. J Allergy Clin Immunol 1995;96:879-885.
14. 14. Jacobsen L, Nüchel-Petersen B, Wihl JÅ, Løwenstein H, Ipsen H. Immunotherapy with partially purified and standardized tree pollen extracts. IV. Results from long-term (6-year) follow-up. Allergy 1997;52:914-920.
15. 15. Jones LA, Jones RM, Sun JV, Tsay YG, Rock HS, Nicolson R. IgE FAST inhibition. A rapid technique for the standardization of pollen allergen extract potency. Ann Allergy 1986;56:222-225.
16. 16. Gleich GJ, Zimmermann EM, Henderson LL, Yunginger JW. Effect of immunotherapy on IgE and IgG antibodies to ragweed antigens. A six-year prospective study. J Allergy Clin Immunol 1982;70:261-271.
17. 17. Witteman AM, Stapel SO, Sjamsoedin DH, Jansen HM, Aalberse RC, van der Zec JS. Fel d 1 specific IgG antibodies induced by natural exposure have blocking activity in skin test. Int Arch Allergy Immunol 1996;109:369-375.
18. 18. Varney VA, Hamid QA, Gaga M, Durham RS. Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late phase cutaneous response. J Clin Invest 1993;92:644-651.